Find Funding
Below are funding resources from the National Institutes of Health (NIH), the UCLA Health Jonsson Comprehensive Cancer Center and UCLA. For more information on UCLA Health JCCC-related funding opportunities, please visit our Internal Funding and External Funding pages.
NIH Funding Resources
UCLA Health Jonsson Comprehensive Cancer Center Funding Resources
Extramural Quarterly Funding Announcement
The UCLA Health JCCC provides an Extramural Quarterly Funding Announcement for UCLA investigators. This includes currently open extramural funding opportunities that are of interest to UCLA investigators. Our latest Announcement is for Q4 2024. You can download in PDF form below.
Download PDF (Link opens in new window)
Extramural Limited Submission Funding Opportunities
Limited extramural funding opportunities are provided as a courtesy to UCLA Health JCCC members. For an opportunity to be included on this list, it must be a Limited Submission Opportunity (LSO) and applications are supported administratively by the Cancer Center's Grants Facilitation Team. Submission instructions are noted below. If you have any questions about a specific LSO listed below, please contact Sarah Anwar .
Listings are generally updated on a bimonthly basis. Entries are ordered by posting date, with most recent postings first. Opportunities are removed from this list once their final application due date has passed.
Posted March 3, 2025
V Foundation Translational (Adult) Cancer Research Grant
This Translational grant is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Research on ANY adult cancer type can be funded. Applicants may propose cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to test hypotheses, develop biomarkers, or mechanisms. The research must apply in a direct way to human beings within 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.
The V Foundation continues to support research on the biological basis of cancer disparities from minority ethnic or racial populations. Research on cancer disparities may be eligible for funding through the Stuart Scott Memorial Cancer Research Fund. Please put forth your best candidate regardless of adult cancer type or cancer disparity focus
Grant Specifics:
- A four-year, $800,000 grant, paid in $200,000 annual installments. Indirect costs up to 10% of direct costs allowed.
- The V Foundation follows NIH Guidelines regarding salary caps. Institutions are welcome to supplement a grant recipient’s salary with institutional funds if desired.
How to apply
If you are interested in being considered for this LOS, please respond with a one-page research summary along with your biosketch to Sarah Anwar at .
Deadline
Research summary and biosketch due to the Cancer Center by March 7, 2025 at 5pm PST.
V Foundation All-Star Translational (Adult) Cancer Research Grant
This All-Star Translational grant is a reinvestment in the most exceptional prior V Foundation grantees and their most innovative ideas. This grant provides funding for high-risk, high-reward, transformative projects that will have a significant impact on our understanding and/or treatment of cancer. Please note it is not required that the previously funded grant was focused on adult translational research nor do the previously funded grant and the newly proposed project need to be linked.
This All-Star Translational grant is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Research on ANY adult cancer type can be funded. Applicants may propose cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to test hypotheses, develop biomarkers, or mechanisms. The research must apply in a direct way to human beings within 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.
The V Foundation continues to support research on the biological basis of cancer disparities from minority ethnic or racial populations. Research on cancer disparities may be eligible for funding through the Stuart Scott Memorial Cancer Research Fund. Please put forth your best candidate regardless of adult cancer type or cancer disparity focus
Grant Specifics:
- A five-year, $1,000,000 grant, paid in $200,000 annual installments. Indirect costs up to 10% of direct costs allowed.
- The V Foundation follows NIH Guidelines regarding salary caps. Institutions are welcome to supplement a grant recipient’s salary with institutional funds if desired.
How to apply
If you are interested in being considered for this LOS, please respond with a one-page research summary along with your biosketch to Sarah Anwar at .
Deadline
Research summary and biosketch due to the Cancer Center by March 7, 2025 at 5pm PST.
UCLA Funding Resources
We want to hear from you!
Help us improve your experience with our services! Click the button below to take a short three-question survey.